Azacitidine to Consolidate and Deepen the Therapeutic Response Achieved by Intensive Induction Treatment in a Young Patient Affected by NPM1mut-AML Who Has Become Ineligible for High-Dose Consolidation.
Chemotherapy（2022）
关键词
Acute myeloid leukemia,Nucleophosmin mutations,Azacitidine,RT-qPCR,Minimal residual disease
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要